Clients

Biomax has had the privilege to work with a wide range of clients: from small to large organizations in industry, academia, government and the non-profit sector to Fortune 500 companies. Some of these clients — leading innovators in biotechnology, drug discovery, diagnostics, fine chemicals, food and plant production, health care and personalized medicine — are listed here.

  • Adisseo
  • BASF
  • Bio-Rad AbD Serotec
  • Boehringer Ingelheim
  • Center for Molecular and Biomolecular Informatics, The Netherlands
  • CIRO+ Center for Expertise for Chronic Organ Failure, The Netherlands
  • Deutsches Zentrum für Lungenforschung
  • Direvo
  • DSM
  • Dupont Pioneer
  • e-Therapeutics
  • Fresenius Biotech
  • Geneart
  • German Patent and Trade Mark Office
  • Innsbruck Medical University, Biocenter
  • KWS SAAT
  • Laboratoire d’Etude de la Dynamique des Protéomes
  • Max Planck Institute of Psychiatry
  • Metanomics
  • MorphoSys
  • National Academy of Agricultural Science, Korea
  • National Institute of Agriculture Biotechnology, Korea
  • National Institute of Agrobiological Sciences, Japan
  • National Institute of Animal Science, Korea
  • National Livestock Research Institute, Korea
  • Nestle Institute of Health Sciences
  • Oncotyrol
  • Orion Corporation
  • Philip Morris
  • Pierre Fabre
  • Roche Diagnostics
  • Sanitätsakademie der Bundeswehr
  • Sanofi Aventis
  • Sanofi Pasteur
  • Syngenta
  • Wacker Chemie

What our clients say about working with Biomax:

— Professor Dr. Emiel Wouters, Chairman of the CIRO+ Board of Directors

“Implementing our ambitious, multidisciplinary approach only became possible through the collaboration with Biomax. The Biomax BioXM system has been in routine use at CIRO+ clinics 24/7 for the past two years and has allowed us to scale up most efficiently.”

— Dr. M. Tesar, Head of Molecular and Cellular Department Immunology Center, Pierre Fabre Medicament

“We have improved our database quality by a centralized bioinformatics system tailored to our needs in analyzing and validating our antibody discovery data. We were impressed how quickly Biomax took our experts’ concepts and turned them into a software solution that efficiently supports our daily work. The improvement to our antibody R&D process has been invaluable.”

— Dr. Marco de Groot, Scientist Bioinformatics at DSM

“By now, we have used the BioXM system in several different areas. The system is outstanding in terms of flexibility and its ability to be tuned to our needs. Its solution-building approach is unprecedented: rolling out a new application to hundreds of end-users takes only weeks. Most importantly, we are able to continuously adapt the system while staying in production, which greatly reduces costs.”

— Dr. Andreas Menze, R&D Information Management, KWS SAAT AG, Germany

“…minimizes manual labor, reduces completion time and improves the efficiency of the entire analysis process.”

— Prof. Wouters, Chairman Board of Directors, CIRO+

“The impact of being able to exploit clinical knowledge effectively using state-of-the-art technology cannot be overestimated. This applies to both improved patient care and better management of treatment costs.”

— Dr. Hans Roubos, Senior Scientist as DSM

“DSM, as a science-based company in health, nutrition and materials, stands for innovation. We are committed to on-going exploration of new frontiers in science and technology as a basis for sustainable growth. Leveraging best-in-class technology, such as BioXM, is part of the strategy.”